Eiger Biopharmaceuticals Inc
(28249U105)
Funds Reporting Holdings of Eiger Biopharmaceuticals Inc according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
683 Capital Management LLC | 1,835,529 | $19,457k | Jun 30, 2019 | Aug 14, 2019 | |
VIVO Capital LLC | 1,791,257 | $18,987k | Jun 30, 2019 | Aug 13, 2019 | |
Broadfin Capital LLC | 1,656,137 | $17,555k | Jun 30, 2019 | Aug 14, 2019 | |
Ecor1 Capital LLC | 1,136,043 | $12,042k | Jun 30, 2019 | Aug 14, 2019 | |
Farallon Capital Management LLC | 1,000,000 | $10,600k | Jun 30, 2019 | Aug 14, 2019 | |
Mangrove Partners | 847,284 | $8,981k | Jun 30, 2019 | Aug 14, 2019 | |
Telemetry Investments LLC | 376,035 | $3,986k | Jun 30, 2019 | Aug 14, 2019 | |
Renaissance Technologies LLC | 298,613 | $3,165k | Jun 30, 2019 | Aug 12, 2019 | |
Driehaus Capital Management LLC | 60,000 | $636k | Jun 30, 2019 | Aug 14, 2019 | |
Tocqueville Asset Management LP | 34,250 | $363k | Jun 30, 2019 | Jul 31, 2019 | |
Sanders Morris Harris LLC | 31,500 | $344k | Jun 30, 2019 | Jul 10, 2019 | |
Spark Investment Management LLC | 14,886 | $157k | Jun 30, 2019 | Aug 12, 2019 | |
Acadian Asset Management LLC | 11,602 | $123k | Jun 30, 2019 | Aug 8, 2019 | |
Prelude Capital Management LLC | 144 | $2k | Jun 30, 2019 | Aug 14, 2019 |